BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29398342)

  • 1. Source of stem cells in haploidentical transplantation.
    Das M
    Lancet Oncol; 2018 Mar; 19(3):e141. PubMed ID: 29398342
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia.
    Nagler A; Dholaria B; Labopin M; Savani BN; Angelucci E; Koc Y; Arat M; Pioltelli P; Sica S; Gülbas Z; Tischer J; Bernasconi P; Pavlu J; Socié G; Blaise D; Rigacci L; Martino M; Diez-Martin JL; Perić Z; Giebel S; Mohty M
    Leukemia; 2020 Oct; 34(10):2766-2775. PubMed ID: 32393841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
    Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.
    Konuma T; Tsukada N; Kanda J; Uchida N; Ohno Y; Miyakoshi S; Kanamori H; Hidaka M; Sakura T; Onizuka M; Kobayashi N; Sawa M; Eto T; Matsuhashi Y; Kato K; Ichinohe T; Atsuta Y; Miyamura K;
    Am J Hematol; 2016 May; 91(5):E284-92. PubMed ID: 26910296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Byrne M; Savani BN; Mohty M; Nagler A
    Exp Hematol; 2016 Jul; 44(7):567-73. PubMed ID: 27106798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
    Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
    Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
    Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplant for acute leukaemia.
    Ramsay NK; Davies S
    Baillieres Clin Haematol; 1991 Apr; 4(2):483-510. PubMed ID: 1912667
    [No Abstract]   [Full Text] [Related]  

  • 10. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
    J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antonio Raichs lecture. Autologous bone marrow transplantation.
    Santos GW
    Sangre (Barc); 1992 Dec; 37(6):471-4. PubMed ID: 1293801
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT.
    Canaani J; Savani BN; Labopin M; Huang XJ; Ciceri F; Arcese W; Tischer J; Koc Y; Bruno B; Gülbas Z; Blaise D; Maertens J; Ehninger G; Mohty M; Nagler A
    Haematologica; 2017 Jun; 102(6):1066-1074. PubMed ID: 28255020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloablative unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: comparison with other graft sources from related and unrelated donors.
    Konuma T; Kato S; Ooi J; Oiwa-Monna M; Tojo A; Takahashi S
    Ann Hematol; 2015 Feb; 94(2):289-96. PubMed ID: 25178518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
    Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
    Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the clinical outcome of unmanipulated haploidentical blood and marrow transplantation.
    Chang YJ; Huang XJ
    Bone Marrow Transplant; 2015 Jun; 50 Suppl 2():S21-3. PubMed ID: 26039202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow.
    Garderet L; Labopin M; Gorin NC; Polge E; Fouillard L; Ehninger GE; Ringden O; Finke J; Tura S; Frassoni F
    Bone Marrow Transplant; 2003 Jan; 31(1):23-9. PubMed ID: 12621503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved clinical outcomes of rhG-CSF-mobilized blood and marrow haploidentical transplantation compared to propensity score-matched rhG-CSF-primed peripheral blood stem cell haploidentical transplantation: a multicenter study.
    Zhao X; Gao F; Zhang X; Wang Y; Xu L; Liu K; Zhao X; Chang Y; Wei H; Chen H; Chen Y; Jiang Z; Huang X
    Sci China Life Sci; 2016 Nov; 59(11):1139-1148. PubMed ID: 27535422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groups.
    Mo XD; Xu LP; Zhang XH; Liu DH; Wang Y; Chen H; Yan CH; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Int J Cancer; 2015 Apr; 136(7):1697-707. PubMed ID: 25138425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
    Ringdén O; Schaffer M; Le Blanc K; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):128-34. PubMed ID: 14750078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.